Real‐world outcomes of advanced melanoma patients not represented in phase III trials-Reference-Cited by-同舟云学术

Real‐world outcomes of advanced melanoma patients not represented in phase III trials

Published:2020-07-04 Issue:12 Volume:147 Page:3461-3470
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zeijl Michiel C. T.¹²,Ismail Rawa K.¹³⁴^ORCID,Wreede Liesbeth C.⁵,Eertwegh Alfonsus J. M.⁶,Boer Anthonius³⁴,Dartel Maaike⁴,Hilarius Doranne L.⁷,Aarts Maureen J. B.⁸,Berkmortel Franchette W. P. J.⁹,Boers‐Sonderen Marye J.¹⁰,Groot Jan‐Willem B.¹¹,Hospers Geke A. P.¹²,Kapiteijn Ellen²,Piersma Djura¹³,Rijn Rozemarijn S.¹⁴,Suijkerbuijk Karijn P. M.¹⁵,ten Tije Albert J.¹⁶,Veldt Astrid A. M.¹⁷,Vreugdenhil Gerard¹⁸,Haanen John B. A. G.¹⁹,Wouters Michel W. J. M¹²⁰

Affiliation:

1. Scientific department Dutch Institute for Clinical Auditing Leiden The Netherlands

2. Department of Medical Oncology Leiden University Medical Center Leiden The Netherlands

3. Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht The Netherlands

4. Medicines Evaluation Board Utrecht The Netherlands

5. Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands

6. Department of Medical Oncology Amsterdam University Medical Centers Amsterdam The Netherlands

7. Department of Pharmacy Red Cross Hospital Beverwijk The Netherlands

8. Department of Medical Oncology Maastricht University Medical Center+ Maastricht The Netherlands

9. Department of Medical Oncology Zuyderland Medical Center Sittard‐Geleen The Netherlands

10. Department of Medical Oncology Radboud University Medical Center Nijmegen The Netherlands

11. Isala Oncology Center Isala, Zwolle The Netherlands

12. Department of Medical Oncology University Medical Centre Groningen Groningen The Netherlands

13. Department of Internal Medicine Medisch Spectrum Twente Enschede The Netherlands

14. Department of Internal Medicine Medical Center Leeuwarden Leeuwarden The Netherlands

15. Department of Medical Oncology University Medical Center Utrecht Utrecht The Netherlands

16. Department of Internal Medicine Amphia Hospital Breda The Netherlands

17. Departments of Medical Oncology and Radiology & Nuclear Medicine Erasmus Medical Centre Rotterdam The Netherlands

18. Department of Internal Medicine Maxima Medical Center Eindhoven The Netherlands

19. Department of Medical Oncology and Immunology Netherlands Cancer Institute Amsterdam The Netherlands

20. Department of Surgical Oncology Netherlands Cancer Institute Amsterdam The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33162

Reference23 articles.

1. Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017

2. The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials

3. The real-world impact of modern treatments on the survival of patients with metastatic melanoma

4. Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

5. Management of Treatment-Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combatting the rising costs of cancer drugs; interventions from a university hospital’s perspective;Frontiers in Pharmacology;2023-08-28

2. Refining skin lesions classification performance using geometric features of superpixels;Scientific Reports;2023-07-15

3. Ipilimumab plus nivolumab in patients with symptomatic melanoma brain metastasis requiring corticosteroids;European Journal of Cancer;2023-07

4. A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors;Cancers;2023-05-26

5. Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry;European Journal of Cancer;2023-03